The University of Chicago Header Logo

Declining use of radiotherapy in stage I and II Hodgkin's disease and its effect on survival and secondary malignancies.

Declining use of radiotherapy in stage I and II Hodgkin's disease and its effect on survival and secondary malignancies. Int J Radiat Oncol Biol Phys. 2012 Feb 01; 82(2):619-25.

View in: PubMed